HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment.

Abstract
Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment have been produced by the Japan Gastroenterological Endoscopy Society in collaboration with the Japan Circulation Society, the Japanese Society of Neurology, the Japan Stroke Society, the Japanese Society on Thrombosis and Hemostasis and the Japan Diabetes Society. Previous guidelines from the Japan Gastroenterological Endoscopy Society have focused primarily on prevention of hemorrhage after gastroenterological endoscopy as a result of continuation ofantithrombotic therapy, without considering the associated risk of thrombosis. The new edition of the guidelines includes discussions of gastroenterological hemorrhage associated with continuation of antithrombotic therapy, as well as thromboembolism associated with withdrawal of antithrombotic therapy.
AuthorsKazuma Fujimoto, Mitsuhiro Fujishiro, Mototsugu Kato, Kazuhide Higuchi, Ryuichi Iwakiri, Choitsu Sakamoto, Shinichiro Uchiyama, Atsunori Kashiwagi, Hisao Ogawa, Kazunari Murakami, Tetsuya Mine, Junji Yoshino, Yoshikazu Kinoshita, Masao Ichinose, Toshiyuki Matsui, Japan Gastroenterological Endoscopy Society
JournalDigestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society (Dig Endosc) Vol. 26 Issue 1 Pg. 1-14 (Jan 2014) ISSN: 1443-1661 [Electronic] Australia
PMID24215155 (Publication Type: Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't)
Copyright© 2013 The Authors. Digestive Endoscopy © 2013 Japan Gastroenterological Endoscopy Society.
Chemical References
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Aspirin
Topics
  • Aspirin (therapeutic use)
  • Contraindications
  • Endoscopy, Gastrointestinal (adverse effects, standards)
  • Fibrinolytic Agents (therapeutic use)
  • Gastrointestinal Hemorrhage (epidemiology, prevention & control)
  • Humans
  • Japan
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Practice Guidelines as Topic
  • Program Development
  • Risk Factors
  • Societies, Medical

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: